logo
ProjectOngoing

Multi-omics research applied to Human ADA2 deficiency and beyond

One of 5,497 projects Taiyo tracks in Belgium.

Source: EU Funding & Tenders Portal

Human adenosine type 2 (ADA2) deficiency is a rare but devastating condition resulting in a complex phenotype of vasculitis (ranging from cutaneous to intracerebral vasculitis with lacunar infarcts), immunodeficiency (recurrent bacterial or viral infections), bone marrow anomalies (cytopenia, aplasia), cancer (lymphoma, leukemia). Mortality is 10%, often in childhood. The mainstay of treatment co

Status
Under Construction
Sector
Aerospace & Defense, Hospital, Government
Location
Belgium
Updated
22 Jul 2026
Source
EU Funding & Tenders Portal

ConstructChat

Ask ConstructChat about Multi-omics research applied to Human ADA2 deficiency and beyond

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Multi-omics research applied to Human ADA2 deficiency and beyond” is an infrastructure initiative in the Aerospace & Defense sector, located in Belgium. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Participants

Sponsoring Agency

Status

Original status

ongoing

Taiyo status

Under Construction

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Human adenosine type 2 (ADA2) deficiency is a rare but devastating condition resulting in a complex phenotype of vasculitis (ranging from cutaneous to intracerebral vasculitis with lacunar infarcts), immunodeficiency (recurrent bacterial or viral infections), bone marrow anomalies (cytopenia, aplasia), cancer (lymphoma, leukemia). Mortality is 10%, often in childhood. The mainstay of treatment consists of anti-TNF blockade for vasculitis. Cytopenia and immunodeficiency respond poorly. Hematopoietic stem cell transplantation is curative in most cases. Although the condition was described in 2014, its pathophysiology is unsolved. From previous work in my laboratory, I have gained insight that ADA2 is likely to play a significant role in antiviral host defense and endothelial function. I thus hypothesize that ADA2 deficiency is an underdiagnosed condition and that complete or partial ADA2 deficiency plays a role in several other common medical conditions. With this research proposal, I aim (1) to unravel the pathophysiology of ADA2 deficiency, to (2) study the significance of ADA2 deficiency in phenocopies of the disease (3) to study the function of ADA2 in vitro (4) to develop new treatment strategies for ADA2 deficiency and its phenocopies. To achieve these aims I will study the prevalence of ADA2 deficiency in cohorts of patients presenting with one or more of the main disease characteristics (e.g. juvenile stroke, aplasia, childhood lymphoma...) by genetic and functional approaches. The genotype, immunophenotype and clinical characteristics of these patients will be studied using the newest technologies. In cell lines and tissue samples of ADA2 deficient patients, we will study the function of ADA2. Finally, we will screen known and novel drugs for their potential use in ADA2 deficiency and phenocopies, even beyond, in cardiovascular disease, cancer, anti-viral host defense.

Location

Country

Belgium

Source

Source

EU Funding & Tenders Portal

URL

More Details

Record type

Project

Sector

Aerospace & Defense, Hospital, Government

Article published date

2025-10-01

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project